• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期使用左炔诺孕酮宫内缓释系统后子宫内膜癌的发生。

Development of endometrial cancer after long-term usage of the levonorgestrel-releasing intrauterine system.

机构信息

Obstetrics and Gynaecology, Queen Elizabeth Hospital, London, London, UK

Obstetrics and Gynaecology, Queen Elizabeth Hospital, London, London, UK.

出版信息

BMJ Case Rep. 2021 May 13;14(5):e242094. doi: 10.1136/bcr-2021-242094.

DOI:10.1136/bcr-2021-242094
PMID:33986013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8126283/
Abstract

A 52-year-old long-term user of the levonorgestrel-releasing intrauterine system (LNG-IUS) presented with vaginal bleeding. Endometrial biopsy was performed and revealed endometrioid adenocarcinoma. The patient had a laparoscopic hysterectomy and bilateral salpingo-oophorectomy. Endometrial cancer is rare in women with LNG-IUS as only seven cases have been published in the literature. Although scientific evidence shows LNG-IUS has a protective effect on the endometrium from developing cancer, our report highlights the importance of clinicians to be vigilant in cases of women with LNG-IUS who develop intermittent vaginal bleeding.

摘要

一位 52 岁的左炔诺孕酮宫内节育系统(LNG-IUS)长期使用者出现阴道出血。进行了子宫内膜活检,结果显示为子宫内膜样腺癌。患者接受了腹腔镜子宫切除术和双侧输卵管卵巢切除术。LNG-IUS 使用者中子宫内膜癌很少见,文献中仅报道了 7 例。尽管科学证据表明 LNG-IUS 对子宫内膜有保护作用,使其不易发生癌症,但我们的报告强调了临床医生在 LNG-IUS 使用者出现间歇性阴道出血时保持警惕的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/8126283/8deb0c8d0aeb/bcr-2021-242094f07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/8126283/2467358f4c83/bcr-2021-242094f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/8126283/a34bf0f4f53d/bcr-2021-242094f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/8126283/e19994398e34/bcr-2021-242094f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/8126283/1ca11e5e8de2/bcr-2021-242094f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/8126283/7c37a0d6bc36/bcr-2021-242094f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/8126283/23e2dd54eb73/bcr-2021-242094f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/8126283/8deb0c8d0aeb/bcr-2021-242094f07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/8126283/2467358f4c83/bcr-2021-242094f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/8126283/a34bf0f4f53d/bcr-2021-242094f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/8126283/e19994398e34/bcr-2021-242094f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/8126283/1ca11e5e8de2/bcr-2021-242094f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/8126283/7c37a0d6bc36/bcr-2021-242094f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/8126283/23e2dd54eb73/bcr-2021-242094f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/8126283/8deb0c8d0aeb/bcr-2021-242094f07.jpg

相似文献

1
Development of endometrial cancer after long-term usage of the levonorgestrel-releasing intrauterine system.长期使用左炔诺孕酮宫内缓释系统后子宫内膜癌的发生。
BMJ Case Rep. 2021 May 13;14(5):e242094. doi: 10.1136/bcr-2021-242094.
2
Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.左炔诺孕酮宫内节育系统治疗子宫内膜增生
Cochrane Database Syst Rev. 2020 Sep 6;9(9):CD012658. doi: 10.1002/14651858.CD012658.pub2.
3
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.左炔诺孕酮宫内节育系统用于辅助三苯氧胺治疗的乳腺癌妇女的子宫内膜保护。
Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD007245. doi: 10.1002/14651858.CD007245.pub4.
4
Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.使用左炔诺孕酮宫内节育系统的女性子宫内膜中的孕激素受体亚型和前列腺素脱氢酶
Hum Reprod. 1998 May;13(5):1210-7. doi: 10.1093/humrep/13.5.1210.
5
Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.长期宫内左炔诺孕酮给药后子宫内膜蜕膜化的形态学和功能特征
Hum Reprod. 1998 May;13(5):1218-24. doi: 10.1093/humrep/13.5.1218.
6
A case of endometrial carcinoma in a long-term Levonorgestrel Intrauterine System (LNG 52 mg-IUS) user.一例长期使用左炔诺孕酮宫内节育系统(LNG 52毫克-IUS)的子宫内膜癌患者。
Post Reprod Health. 2017 Mar;23(1):13-14. doi: 10.1177/2053369117691201. Epub 2017 Jan 31.
7
Endometrial adenocarcinoma following insertion of the levonorgestrel-releasing intrauterine system (mirena) in a 36-year-old woman.一名36岁女性在植入左炔诺孕酮宫内节育系统(曼月乐)后发生子宫内膜腺癌。
Int J Gynecol Cancer. 2006 May-Jun;16(3):1445-7. doi: 10.1111/j.1525-1438.2006.00546.x.
8
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.左炔诺孕酮宫内节育系统用于辅助他莫昔芬治疗的乳腺癌女性的子宫内膜保护
Cochrane Database Syst Rev. 2015 Dec 9;2015(12):CD007245. doi: 10.1002/14651858.CD007245.pub3.
9
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.左炔诺孕酮宫内节育系统用于辅助他莫昔芬治疗的乳腺癌女性的子宫内膜保护
Cochrane Database Syst Rev. 2009 Oct 7(4):CD007245. doi: 10.1002/14651858.CD007245.pub2.
10
Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium.左炔诺孕酮对人子宫内膜雄激素受体及2型17β-羟类固醇脱氢酶表达的局部调节作用
Hum Reprod. 2003 Dec;18(12):2610-7. doi: 10.1093/humrep/deg510.

引用本文的文献

1
Women's health, hormonal balance, and personal autonomy.女性健康、激素平衡与个人自主权。
Front Med (Lausanne). 2023 Jun 30;10:1167504. doi: 10.3389/fmed.2023.1167504. eCollection 2023.

本文引用的文献

1
The current state of molecular testing in the treatment of patients with solid tumors, 2019.2019 年实体瘤患者治疗中分子检测的现状。
CA Cancer J Clin. 2019 Jul;69(4):305-343. doi: 10.3322/caac.21560. Epub 2019 May 22.
2
Malignant endometrial polyp in woman with the levonorgestrel intrauterine system - a case report.带左炔诺孕酮宫内节育系统的女性中的恶性子宫内膜息肉——病例报告。
Gynecol Endocrinol. 2019 Feb;35(2):112-114. doi: 10.1080/09513590.2018.1491028. Epub 2018 Nov 19.
3
BGCS uterine cancer guidelines: Recommendations for practice.
BGCS子宫癌指南:实践建议。
Eur J Obstet Gynecol Reprod Biol. 2017 Jun;213:71-97. doi: 10.1016/j.ejogrb.2017.04.015. Epub 2017 Apr 13.
4
Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial.腹腔镜全子宫切除术与经腹全子宫切除术治疗Ⅰ期子宫内膜癌无病生存的效果比较:一项随机临床试验。
JAMA. 2017 Mar 28;317(12):1224-1233. doi: 10.1001/jama.2017.2068.
5
A case of endometrial carcinoma in a long-term Levonorgestrel Intrauterine System (LNG 52 mg-IUS) user.一例长期使用左炔诺孕酮宫内节育系统(LNG 52毫克-IUS)的子宫内膜癌患者。
Post Reprod Health. 2017 Mar;23(1):13-14. doi: 10.1177/2053369117691201. Epub 2017 Jan 31.
6
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.左炔诺孕酮宫内节育系统用于辅助他莫昔芬治疗的乳腺癌女性的子宫内膜保护
Cochrane Database Syst Rev. 2015 Dec 9;2015(12):CD007245. doi: 10.1002/14651858.CD007245.pub3.
7
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.ESMO-ESGO-ESTRO 子宫内膜癌共识会议:诊断、治疗和随访。
Ann Oncol. 2016 Jan;27(1):16-41. doi: 10.1093/annonc/mdv484. Epub 2015 Dec 2.
8
Endometrial cancer.子宫内膜癌。
Lancet. 2016 Mar 12;387(10023):1094-1108. doi: 10.1016/S0140-6736(15)00130-0. Epub 2015 Sep 6.
9
Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland.芬兰女性使用左炔诺孕酮宫内节育系统的癌症风险。
Obstet Gynecol. 2014 Aug;124(2 Pt 1):292-299. doi: 10.1097/AOG.0000000000000356.
10
Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis.肿瘤大小、浸润深度和组织学分级作为子宫内膜癌淋巴结转移的预后因素:一项 SEER 分析。
Gynecol Oncol. 2014 May;133(2):216-20. doi: 10.1016/j.ygyno.2014.02.011. Epub 2014 Feb 16.